Literature DB >> 32693969

Zinc Plasma Status and Sensory Perception in Nondialysis Chronic Kidney Disease Patients.

Ana Paula Dos Santos Rocha Tavares1, Denise Mafra2, Viviane de Oliveira Leal3, Manuele Dos Santos Gama4, Rayanne Mocarzel Moraes de Freitas Vieira4, Isabela De Souza da Costa Brum4, Natalia Alvarenga Borges5, Alexandra Anastacio Silva6.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the association between zinc plasma levels and sensory perception in patients with chronic kidney disease (CKD).
METHODS: A cross-sectional study with 21 nondialysis CKD patients (11 men, 51.1 ± 7.1 years, body mass index 27.9 ± 7.1 kg/m2, estimated glomerular filtration rate 32.7 ± 19.9 mL/min) and 22 non-CKD volunteers (10 men, 49.8 ± 8.3 years, body mass index 28.5 ± 5.4 kg/m2) was conducted. Blood samples were collected to obtain plasma for zinc analysis. Anthropometric and biochemical parameters, as well as food intake and salivary flow rate, were also evaluated. Taste sensory perception for sweet, acidic, bitter, and salty flavors was determined by the "three-drop method," with 4 concentrations of the 4 basic tastes.
RESULTS: As expected, zinc plasma levels were significantly lower in CKD patients (70.1 ± 19.2ug/dL) when compared with the control group participants (123.2 ± 24.6 μg dL) (P ˂ .0001). The bitter taste perception was lower in the CKD group (p˂0.0001). Our findings showed that sensitivity to sour (P = .047), salty (P = .03), and bitter tastes was significantly lower in participants with lower zinc plasma levels. Also, bitter taste sensitivity was lower in participants with less zinc intake (P = .038). When grouping control subjects and CKD patients, significant correlations were observed between zinc plasma levels and the number of correct answers for bitter taste (r = 0.49, P = .001), number of correct answers for salty taste (r = 0.30, P = .048), and total score of correct answers (r = 0.30, P = .044).
CONCLUSIONS: Reduced zinc plasma levels in nondialysis CKD patients may be associated with lower perception of bitter, sour, and salty tastes and strategies to restore these levels are crucial due many factors, including food preferences and intake.
Copyright © 2020 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32693969     DOI: 10.1053/j.jrn.2020.05.012

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  5 in total

Review 1.  Role of Zinc in Diabetic Kidney Disease.

Authors:  Guido Gembillo; Luca Visconti; Alfio Edoardo Giuffrida; Vincenzo Labbozzetta; Luigi Peritore; Antonella Lipari; Vincenzo Calabrese; Giorgina Barbara Piccoli; Massimo Torreggiani; Rossella Siligato; Domenico Santoro
Journal:  Nutrients       Date:  2022-03-24       Impact factor: 5.717

Review 2.  Understanding Development of Malnutrition in Hemodialysis Patients: A Narrative Review.

Authors:  Sharmela Sahathevan; Ban-Hock Khor; Hi-Ming Ng; Abdul Halim Abdul Gafor; Zulfitri Azuan Mat Daud; Denise Mafra; Tilakavati Karupaiah
Journal:  Nutrients       Date:  2020-10-15       Impact factor: 5.717

Review 3.  A Systematic Review of Salt Taste Function and Perception Impairments in Adults with Chronic Kidney Disease.

Authors:  Sze-Yen Tan; Paridhi Tuli; Giecella Thio; Breannah Noel; Bailey Marshall; Zhen Yu; Rachael Torelli; Sarah Fitzgerald; Maria Chan; Robin M Tucker
Journal:  Int J Environ Res Public Health       Date:  2022-10-03       Impact factor: 4.614

Review 4.  Association of Zinc Deficiency with Development of CVD Events in Patients with CKD.

Authors:  Shinya Nakatani; Katsuhito Mori; Tetsuo Shoji; Masanori Emoto
Journal:  Nutrients       Date:  2021-05-15       Impact factor: 5.717

5.  The association between olfactory and gustatory dysfunction and chronic kidney disease.

Authors:  Api Chewcharat; Elizabeth A Phipps; Khushboo Bhatia; Sahir Kalim; Andrew S Allegretti; Meghan E Sise; Teodor G Păunescu; Rituvanthikaa Seethapathy; Sagar U Nigwekar
Journal:  BMC Nephrol       Date:  2022-01-18       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.